Chongqing Precision Bio

China

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 2
12 in Phase 1
Next date
BCMA CAR-T cells, Phase 1/2 trial completes
Drugs
16
in active trials · 22 in all
Trials
26 active
50 since 2021

Drugs16

DrugHow it worksPartnerStageNext dateDetails
—
Phase 1/2 31 Dec 2026Phase 1/2 trial completes
—
Phase 1/2 31 Dec 2026Phase 1/2 trial completes
—
Phase 1/2 31 Dec 2026Phase 1/2 trial completes
—
Phase 2 31 Dec 2028Phase 2 trial completes
—
Phase 1 31 Dec 2026Phase 1 trial completes
—
Phase 1 31 Dec 2026Phase 1 trial completes
In vivo CD19 CAR-T
Phase 1 Dec 2026Phase 1 trial completes
—
Phase 1 31 Mar 2027Phase 1 trial completes
—
Phase 1 30 Jun 2027Phase 1 trial completes
—
Phase 1 31 Jul 2027Phase 1 trial completes
—
Phase 1 1 Nov 2027Phase 1 trial completes
In vivo CAR-T, target not disclosed
Phase 1 31 Dec 2027Phase 1 trial completes
—
Phase 1 Apr 2028Phase 1 trial completes
In vivo CAR-T (CD19, BCMA and CD70 CARs), lentiviral
Early Phase 1 30 May 2029Early Phase 1 trial completes
—
Phase 1 —
—
Phase 1 —

About

No active trial
6 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021

Follow Chongqing Precision Bio

Following is part of Solo: you see every change to Chongqing Precision Bio the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in